Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen Licenses System Biosciences' Exosome Isolation Technology

NEW YORK (GenomeWeb) – System Biosciences said today that Qiagen has signed a non-exclusive, worldwide license for SBI's ExoQuick exosome isolation technology for research use.

Qiagen intends to use the technology in its precipitation-based miRcury Exosome Kits, complementing its spin column-based exoEasy and exoRNeasy products.

"Qiagen's license demonstrates the value of ExoQuick technology for high-throughput, scalable isolation of exosomes from a range of biofluid samples," Jake Lesnik, vice president of commercial development at SBI, said in a statement. "The license agreement also demonstrates SBI's commitment to protecting its proprietary ExoQuick technology, which is used by thousands of researchers globally for fast and efficient exosome isolation."

Besides ExoQuick, Palo Alto, California-based SBI provides several exosome research tools and services including ExoFBS, ExoFlow, Exo-fect, and ExoGlow technologies, as well as Exo-NGS and ExoMS services for exosomal RNA-seq and proteomics analysis, respectively.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.